Literature DB >> 33512481

Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma.

Christopher R Bolen1, Federico Mattiello2, Michael Herold3, Wolfgang Hiddemann4, Sarah Huet5,6,7, Wolfram Klapper8, Robert Marcus9, Farheen Mir10, Gilles Salles5,11, Oliver Weigert12,13,14, Tina Nielsen2, Mikkel Z Oestergaard15, Jeffrey M Venstrom16.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33512481      PMCID: PMC8120142          DOI: 10.1182/blood.2020008119

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  13 in total

1.  Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.

Authors:  Daryl Tan; Sandra J Horning; Richard T Hoppe; Ronald Levy; Saul A Rosenberg; Bronislava M Sigal; Roger A Warnke; Yasodha Natkunam; Summer S Han; Alan Yuen; Sylvia K Plevritis; Ranjana H Advani
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

2.  Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles.

Authors:  Annette M Staiger; Eva Hoster; Vindi Jurinovic; Stefan Winter; Ellen Leich; Claudia Kalla; Peter Möller; Heinz-Wolfram Bernd; Alfred C Feller; Karoline Koch; Wolfram Klapper; Harald Stein; Martin-Leo Hansmann; Sylvia Hartmann; Martin Dreyling; Oliver Weigert; Wolfgang Hiddemann; Klaus Herfarth; Andreas Rosenwald; Marianne Engelhard; German Ott; Heike Horn
Journal:  Blood       Date:  2020-01-16       Impact factor: 22.113

3.  The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association.

Authors:  Robert Kridel; Luc Xerri; Bénédicte Gelas-Dore; King Tan; Pierre Feugier; Ayesha Vawda; Danielle Canioni; Pedro Farinha; Sami Boussetta; Alden A Moccia; Pauline Brice; Elizabeth A Chavez; Alastair H Kyle; David W Scott; Ashley D Sanders; Bettina Fabiani; Graham W Slack; Andrew I Minchinton; Corinne Haioun; Joseph M Connors; Laurie H Sehn; Christian Steidl; Randy D Gascoyne; Gilles Salles
Journal:  Clin Cancer Res       Date:  2015-04-13       Impact factor: 12.531

4.  A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

Authors:  Emmanuel Bachy; Matthew J Maurer; Thomas M Habermann; Bénédicte Gelas-Dore; Delphine Maucort-Boulch; Jane A Estell; Eric Van den Neste; Réda Bouabdallah; Emmanuel Gyan; Andrew L Feldman; Joan Bargay; Alain Delmer; Susan L Slager; Maria Gomes da Silva; Olivier Fitoussi; David Belada; Hervé Maisonneuve; Tanin Intragumtornchai; Stephen M Ansell; Thierry Lamy; Peggy Dartigues; Brian K Link; John F Seymour; James R Cerhan; Gilles Salles
Journal:  Blood       Date:  2018-04-17       Impact factor: 22.113

Review 5.  How I treat early-relapsing follicular lymphoma.

Authors:  Carla Casulo; Paul M Barr
Journal:  Blood       Date:  2019-01-30       Impact factor: 22.113

6.  Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.

Authors:  Alessandro Pastore; Vindi Jurinovic; Robert Kridel; Eva Hoster; Annette M Staiger; Monika Szczepanowski; Christiane Pott; Nadja Kopp; Mark Murakami; Heike Horn; Ellen Leich; Alden A Moccia; Anja Mottok; Ashwini Sunkavalli; Paul Van Hummelen; Matthew Ducar; Daisuke Ennishi; Hennady P Shulha; Christoffer Hother; Joseph M Connors; Laurie H Sehn; Martin Dreyling; Donna Neuberg; Peter Möller; Alfred C Feller; Martin L Hansmann; Harald Stein; Andreas Rosenwald; German Ott; Wolfram Klapper; Michael Unterhalt; Wolfgang Hiddemann; Randy D Gascoyne; David M Weinstock; Oliver Weigert
Journal:  Lancet Oncol       Date:  2015-08-06       Impact factor: 41.316

7.  Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

Authors:  Massimo Federico; Monica Bellei; Luigi Marcheselli; Stefano Luminari; Armando Lopez-Guillermo; Umberto Vitolo; Barbara Pro; Stefano Pileri; Alessandro Pulsoni; Pierre Soubeyran; Sergio Cortelazzo; Giovanni Martinelli; Maurizio Martelli; Luigi Rigacci; Luca Arcaini; Francesco Di Raimondo; Francesco Merli; Elena Sabattini; Peter McLaughlin; Philippe Solal-Céligny
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

8.  Follicular lymphoma international prognostic index.

Authors:  Philippe Solal-Céligny; Pascal Roy; Philippe Colombat; Josephine White; Jim O Armitage; Reyes Arranz-Saez; Wing Y Au; Monica Bellei; Pauline Brice; Dolores Caballero; Bertrand Coiffier; Eulogio Conde-Garcia; Chantal Doyen; Massimo Federico; Richard I Fisher; Javier F Garcia-Conde; Cesare Guglielmi; Anton Hagenbeek; Corinne Haïoun; Michael LeBlanc; Andrew T Lister; Armando Lopez-Guillermo; Peter McLaughlin; Noël Milpied; Pierre Morel; Nicolas Mounier; Stephen J Proctor; Ama Rohatiner; Paul Smith; Pierre Soubeyran; Hervé Tilly; Umberto Vitolo; Pier-Luigi Zinzani; Emanuele Zucca; Emili Montserrat
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113

9.  A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.

Authors:  Minna Taskinen; Marja-Liisa Karjalainen-Lindsberg; Heidi Nyman; Leena-Maija Eerola; Sirpa Leppä
Journal:  Clin Cancer Res       Date:  2007-10-01       Impact factor: 12.531

10.  Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.

Authors:  Robert Marcus; Andrew Davies; Kiyoshi Ando; Wolfram Klapper; Stephen Opat; Carolyn Owen; Elizabeth Phillips; Randeep Sangha; Rudolf Schlag; John F Seymour; William Townsend; Marek Trněný; Michael Wenger; Günter Fingerle-Rowson; Kaspar Rufibach; Tom Moore; Michael Herold; Wolfgang Hiddemann
Journal:  N Engl J Med       Date:  2017-10-05       Impact factor: 91.245

View more
  1 in total

Review 1.  Follicular lymphoma: is there an optimal way to define risk?

Authors:  Carla Casulo
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.